Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases
Patricia Navvuga MSc , Erik Lenguerrand PhD , Rita Patel PhD , Jonathan M. French BMBS , Ashley W. Blom PhD , Michael R. Whitehouse PhD , Elsa M.R. Marques PhD
{"title":"Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases","authors":"Patricia Navvuga MSc , Erik Lenguerrand PhD , Rita Patel PhD , Jonathan M. French BMBS , Ashley W. Blom PhD , Michael R. Whitehouse PhD , Elsa M.R. Marques PhD","doi":"10.1016/j.jval.2025.04.2170","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>We investigated 10-year revision risks, hospital admission costs, and quality of life for patients in the year after elective primary and revision total hip replacement (THR), overall and by implant bearing materials and fixation combination.</div></div><div><h3>Methods</h3><div>We analyzed linked National Joint Registry, Hospital Episode Statistics, and Patient Reported Outcome Measure databases for adults undergoing elective primary THR in England (2009-2018). Implants were classified by bearing material combinations (cobalt chrome and stainless steel, delta or alumina ceramics, and highly or nonhighly crosslinked polyethylene [HCLPE]) and fixation (cemented, uncemented, and hybrid). We estimated hazard ratios with flexible parametric survival models, and generalized linear models for costs and quality of life. Missing quality-of-life data were imputed using multiple imputation.</div></div><div><h3>Results</h3><div>We analyzed 550 760 elective primary (mean age = 69, SD = 10.7) and 9590 subsequent revision THRs. On average, a primary THR costed, £10 365 (95% CI £10 350-£10 381); quality of life after primary was 0.786 (95% CI 0.785- 0.786), and 10-year revision risk was 2.4% (95% CI 2.08%-2.78%). First and second revisions costed, on average, £20 387 and £24 290, with mean quality-of-life scores of 0.609 and 0.502, respectively. Compared with cemented cobalt chrome and stainless steel on HCLPE, cemented delta-on-HCLPE, uncemented delta-on-HCLPE, and hybrid delta-on-HCLPE, alumina-on-HCLPE, delta-on-delta and alumina-on-alumina were associated with lower 1-year costs, improved quality of life, and lower 10-year revision risks.</div></div><div><h3>Conclusions</h3><div>Revision surgery costs double than that of an elective primary with drastically lower quality of life. Bearing materials and fixation were associated with varying 1-year costs, quality-of-life scores and revision risks. Although observational data may be affected by unmeasured confounding, our findings could help guide procurement decisions given changing trends in implant choice.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"28 8","pages":"Pages 1176-1184"},"PeriodicalIF":6.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1098301525023654","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
We investigated 10-year revision risks, hospital admission costs, and quality of life for patients in the year after elective primary and revision total hip replacement (THR), overall and by implant bearing materials and fixation combination.
Methods
We analyzed linked National Joint Registry, Hospital Episode Statistics, and Patient Reported Outcome Measure databases for adults undergoing elective primary THR in England (2009-2018). Implants were classified by bearing material combinations (cobalt chrome and stainless steel, delta or alumina ceramics, and highly or nonhighly crosslinked polyethylene [HCLPE]) and fixation (cemented, uncemented, and hybrid). We estimated hazard ratios with flexible parametric survival models, and generalized linear models for costs and quality of life. Missing quality-of-life data were imputed using multiple imputation.
Results
We analyzed 550 760 elective primary (mean age = 69, SD = 10.7) and 9590 subsequent revision THRs. On average, a primary THR costed, £10 365 (95% CI £10 350-£10 381); quality of life after primary was 0.786 (95% CI 0.785- 0.786), and 10-year revision risk was 2.4% (95% CI 2.08%-2.78%). First and second revisions costed, on average, £20 387 and £24 290, with mean quality-of-life scores of 0.609 and 0.502, respectively. Compared with cemented cobalt chrome and stainless steel on HCLPE, cemented delta-on-HCLPE, uncemented delta-on-HCLPE, and hybrid delta-on-HCLPE, alumina-on-HCLPE, delta-on-delta and alumina-on-alumina were associated with lower 1-year costs, improved quality of life, and lower 10-year revision risks.
Conclusions
Revision surgery costs double than that of an elective primary with drastically lower quality of life. Bearing materials and fixation were associated with varying 1-year costs, quality-of-life scores and revision risks. Although observational data may be affected by unmeasured confounding, our findings could help guide procurement decisions given changing trends in implant choice.
期刊介绍:
Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.